AI Chatbot for Migraine Management in Hong Kong Women
NCT06920602 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49
Last updated 2025-12-15
Summary
The goal of this randomized crossover trial is to examine whether the AI-empowered chatbot will effectively collect comprehensive migraine feature data and demonstrate higher compliance, accuracy, utilization, acceptability, feasibility, and validity in migraine feature tracking compared to traditional paper-based migraine diaries among Hong Kong women with migraine.
Participants will use different tools (AI-empowered voice-interactive chatbot or paper migraine diary) for migraine tracking. Participants will be randomly allocated to one of two intervention sequences: (1) AI-empowered voice-interactive chatbot followed by paper migraine diary, or (2) paper migraine diary followed by AI-empowered voice-interactive chatbot. The study will consist of two intervention periods, each lasting one month, with a 1:1 allocation ratio.
Conditions
Interventions
- DEVICE
-
AI-empowered voice-interactive chatbot
Participants will interact with the chatbot on a daily basis to record their migraine experiences. They will be asked to initiate a conversation with the chatbot whenever they experience a migraine attack and provide the required information, including the date and time of the attack, presence of aura, migraine intensity, accompanying symptoms, triggers, and medication use. The chatbot will engage participants in a conversation to collect these data points and store them securely within the chatbot system.
- DEVICE
-
Paper migraine diary
Participants will manually document their migraine experiences on the paper migraine diary, including the date and time of the attack, presence of aura, migraine intensity, accompanying symptoms, triggers, and medication use.
- DEVICE
-
Paper migraine diary
Participants will manually document their migraine experiences on the paper migraine diary, including the date and time of the attack, presence of aura, migraine intensity, accompanying symptoms, triggers, and medication use.
- DEVICE
-
AI-empowered voice-interactive chatbot
Participants will interact with the chatbot on a daily basis to record their migraine experiences. They will be asked to initiate a conversation with the chatbot whenever they experience a migraine attack and provide the required information, including the date and time of the attack, presence of aura, migraine intensity, accompanying symptoms, triggers, and medication use. The chatbot will engage participants in a conversation to collect these data points and store them securely within the chatbot system.
Sponsors & Collaborators
-
Nethersole Institute of Continuing Holistic Health Education (NICHE)
collaborator UNKNOWN -
The Hong Kong Polytechnic University
lead OTHER
Principal Investigators
-
Yao Jie Xie, PhD · The Hong Kong Polytechnic Univeristy
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-01
- Primary Completion
- 2025-11-01
- Completion
- 2025-11-01
Countries
- Hong Kong
Study Locations
More Related Trials
-
My Healthy Diary - An Electronic Diary for Remote Migraine Monitoring
NCT04828941 ·Status: UNKNOWN ·Phase: NA
-
A Registry Study on Rimegepant for the Treatment of Migraine Participants in Guangdong-Hong Kong-Macao Greater Bay Area
NCT06221267 ·Status: COMPLETED
-
Clinical Features and Current Treatment of Primary Headache
NCT06883955 ·Status: NOT_YET_RECRUITING
-
A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic Migraines
NCT01813591 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Botulinum Toxin Type A for Injection(HengLi®)for Prophylactic Treatment of Chronic Migraine
NCT02291380 ·Status: UNKNOWN ·Phase: PHASE3
-
A Pragmatic Trial of Machine Prescription for Migraine
NCT06893874 ·Status: RECRUITING
-
Acupuncture in Chronic Migraine: A Randomized Controlled Trial
NCT01096420 ·Status: COMPLETED ·Phase: NA
-
Mind Body Intervention for Chronic Migraine Headaches
NCT06690060 ·Status: RECRUITING ·Phase: NA
-
Tai Chi for the Prophylaxis of Episodic Migraine: the Efficacy Examination and Mechanism Exploration
NCT05690737 ·Status: RECRUITING ·Phase: NA
-
Sequential, Multiple Assignment, Double Randomized Preference, Migraine Behavioral Trial
NCT06170281 ·Status: RECRUITING ·Phase: NA
-
MEDUSA Study - Migraine: Evaluation of Diagnosis, Utilisation of Services and Application
NCT05979285 ·Status: COMPLETED ·Phase: NA
-
nVNS for the Prevention and Treatment of Primary Headache
NCT06277063 ·Status: RECRUITING ·Phase: NA
-
Migraine Manager (R01)
NCT04567355 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study With Migraid Device in Acute, Early Treatment of Migraine With Typical Aura
NCT00126035 ·Status: COMPLETED ·Phase: NA
-
Pilot Study for a Machine Learning Test for Migraine
NCT05517200 ·Status: UNKNOWN
-
Laser Acupuncture for Chronic Migraine
NCT06219694 ·Status: RECRUITING ·Phase: NA
-
Use of a Treatment Benefit Questionnaire in Patients With Chronic Migraine Treated With OnabotulinumtoxinA (BOTOX®)
NCT01833130 ·Status: COMPLETED ·Phase: PHASE4
-
Non-Invasive Neurostimulation For the Relief of Symptoms Associated With Migraine
NCT01532830 ·Status: COMPLETED ·Phase: NA
-
Chordate System S020 Acute Migraine Clinical Investigation
NCT02185703 ·Status: TERMINATED ·Phase: NA
-
Feasibility and Effectiveness of Home-behavioral Program for Adolescents With Migraine
NCT04604977 ·Status: COMPLETED ·Phase: NA
-
Migraine and Infertility
NCT03831659 ·Status: COMPLETED
-
A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications
NCT06701526 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
One-Day Intervention for Depression and Impairment in Migraine Patients
NCT02108678 ·Status: COMPLETED ·Phase: NA
-
Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
NCT00534560 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Middle Meningeal Artery Embolization for Treatment of Intractable Migraine
NCT06029153 ·Status: COMPLETED ·Phase: NA